Browse Drug Recalls
8 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 8 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 8 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 20, 2024 | Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San F... | Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo ... | Class II | Genentech, Inc. |
| Oct 18, 2022 | Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton contain... | Defective Delivery System: Commercial implants do not meet the filed specification for the intend... | Class III | Genentech Inc |
| Jun 9, 2021 | Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For... | Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content we... | Class II | Genentech Inc |
| Apr 20, 2021 | Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total vo... | Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA)... | Class III | Genentech Inc |
| Mar 13, 2017 | Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Swit... | Superpotent Drug: An oversized tablet was found in a bottle. | Class II | Genentech Inc. |
| Sep 20, 2012 | Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genente... | Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin A... | Class II | Genentech Inc |
| Sep 20, 2012 | Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genente... | Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin A... | Class II | Genentech Inc |
| Jul 30, 2012 | Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20... | Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials ... | Class I | Genentech Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.